New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Mark Cuban: A Master Disrupter for American Health...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
High-speed imaging tracks live brain cell activity...
World is falling behind on UN's child mortality Sustainable ...
April 16,2026
Health literacy initiative improves discharge education, rea...
April 15,2026
Constipation is common, but with simple changes, you can man...
April 14,2026
Children and teenagers more open to meat free diets—but stru...
April 13,2026
3D-printed ATLAS platform helps model cancer cell clusters b...
April 12,2026
3 million-cell map shows menopause reshapes breast tissue, p...
April 11,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Los 20 tipos de cáncer más comunes: causas, síntomas y tratamiento

Los 20 tipos de cáncer más comunes: causas, síntomas y tratamiento

Los 20 tipos de cáncer más comunes: causas, síntomas y tratamientoRepasamos cuáles son los subtipos de esta enfermedad que afectan a más gente a nivel mundial.Pol Bertran PrietoMicrobiólogo, divulgado
World medicine November 28,2023
Los 20 tipos de cáncer más comunes: causas, síntomas y tratamiento

Los 20 tipos de cáncer más comunes: causas, síntomas y tratamiento

Los 20 tipos de cáncer más comunes: causas, síntomas y tratamientoRepasamos cuáles son los subtipos de esta enfermedad que afectan a más gente a nivel mundial.Pol Bertran PrietoMicrobiólogo, divulgado
World medicine November 28,2023
Today's News
Why is Alzheimer’s disease so difficult to treat? ...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
In the drive to deprescribe, heartburn drug study teaches key lessons

In the drive to deprescribe, heartburn drug study teaches key lessons

byUniversity of MichiganCredit: Pixabay/CC0 Public DomainWhether it's costs, safety risks, or "pill fatigue" they're trying to reduce, many health systems and clinics have star
Breakthroughs April 28,2024
In the drive to deprescribe, heartburn drug study teaches key lessons

In the drive to deprescribe, heartburn drug study teaches key lessons

byUniversity of MichiganCredit: Pixabay/CC0 Public DomainWhether it's costs, safety risks, or "pill fatigue" they're trying to reduce, many health systems and clinics have star
Breakthroughs April 28,2024
Popular diabetes drugs do not increase thyroid cancer risk, study suggests

Popular diabetes drugs do not increase thyroid cancer risk, study suggests

byKarolinska InstitutetCredit: CC0 Public DomainDrugs known as GLP-1 analogs have become increasingly popular to treat diabetes and obesity, but there have been concerns that they might increase
Breakthroughs April 28,2024
Popular diabetes drugs do not increase thyroid cancer risk, study suggests

Popular diabetes drugs do not increase thyroid cancer risk, study suggests

byKarolinska InstitutetCredit: CC0 Public DomainDrugs known as GLP-1 analogs have become increasingly popular to treat diabetes and obesity, but there have been concerns that they might increase
Breakthroughs April 28,2024
AACR: Cadonilimab plus chemo beneficial for gastric adenocarcinoma

AACR: Cadonilimab plus chemo beneficial for gastric adenocarcinoma

by Elana GotkineFor patients with gastric/gastroesophageal junction (G/GEJ) adenocarcinoma, cadonilimab plus chemotherapy is associated with improved overall survival and progression-free survival, ac
Oncology April 28,2024
AACR: Cadonilimab plus chemo beneficial for gastric adenocarcinoma

AACR: Cadonilimab plus chemo beneficial for gastric adenocarcinoma

by Elana GotkineFor patients with gastric/gastroesophageal junction (G/GEJ) adenocarcinoma, cadonilimab plus chemotherapy is associated with improved overall survival and progression-free survival, ac
Oncology April 28,2024
Chelation therapy does not improve outcomes after heart attack

Chelation therapy does not improve outcomes after heart attack

byAmerican College of CardiologyCredit: Pixabay/CC0 Public DomainPeople with diabetes who had suffered a heart attack derived no clinical benefit from edetate disodium-based chelation, a therapy
Breakthroughs April 28,2024
Chelation therapy does not improve outcomes after heart attack

Chelation therapy does not improve outcomes after heart attack

byAmerican College of CardiologyCredit: Pixabay/CC0 Public DomainPeople with diabetes who had suffered a heart attack derived no clinical benefit from edetate disodium-based chelation, a therapy
Breakthroughs April 28,2024
Topical tranexamic acid found inferior to intravenous administration

Topical tranexamic acid found inferior to intravenous administration

byAmerican College of CardiologyCredit: Pixabay/CC0 Public DomainAdministering tranexamic acid (TxA), a drug used to reduce bleeding during heart surgery topically rather than intravenously did
Breakthroughs April 28,2024
Topical tranexamic acid found inferior to intravenous administration

Topical tranexamic acid found inferior to intravenous administration

byAmerican College of CardiologyCredit: Pixabay/CC0 Public DomainAdministering tranexamic acid (TxA), a drug used to reduce bleeding during heart surgery topically rather than intravenously did
Breakthroughs April 28,2024
FDA approves new antibiotic for three indications

FDA approves new antibiotic for three indications

by Lori SolomonThe U.S. Food and Drug Administration has approved the antibiotic Zevtera (ceftobiprole medocaril sodium for injection) for three different indications, including treatment of adults wi
Breakthroughs April 28,2024
FDA approves new antibiotic for three indications

FDA approves new antibiotic for three indications

by Lori SolomonThe U.S. Food and Drug Administration has approved the antibiotic Zevtera (ceftobiprole medocaril sodium for injection) for three different indications, including treatment of adults wi
Breakthroughs April 28,2024
Study identifies factors that affect antibiotic prescribing for acne

Study identifies factors that affect antibiotic prescribing for acne

by Elana GotkineMultiple salient factors affect long-term antibiotic prescribing practices for acne, according to a studypublishedinJAMA Dermatology.Ronnie A. Festok, from the Emory
Breakthroughs April 28,2024
Study identifies factors that affect antibiotic prescribing for acne

Study identifies factors that affect antibiotic prescribing for acne

by Elana GotkineMultiple salient factors affect long-term antibiotic prescribing practices for acne, according to a studypublishedinJAMA Dermatology.Ronnie A. Festok, from the Emory
Breakthroughs April 28,2024
Migraine sufferers in England may soon be able to access a preventative drug: Atogepant

Migraine sufferers in England may soon be able to access a preventative drug: Atogepant

by Anna Andreou,The ConversationCredit: Unsplash/CC0 Public DomainA drug that can help prevent migraines could soon be available on the NHS. Atogepant (brand name: Aquipta) was recently recommen
Breakthroughs April 28,2024
Migraine sufferers in England may soon be able to access a preventative drug: Atogepant

Migraine sufferers in England may soon be able to access a preventative drug: Atogepant

by Anna Andreou,The ConversationCredit: Unsplash/CC0 Public DomainA drug that can help prevent migraines could soon be available on the NHS. Atogepant (brand name: Aquipta) was recently recommen
Breakthroughs April 28,2024
Study shows web app effective in determining access to statins without a prescription

Study shows web app effective in determining access to statins without a prescription

byAmerican College of CardiologyCredit: Pixabay/CC0 Public DomainUsing a web application to qualify individuals for treatment with a non-prescription statin closely matched the results of clinic
Breakthroughs April 28,2024
Study shows web app effective in determining access to statins without a prescription

Study shows web app effective in determining access to statins without a prescription

byAmerican College of CardiologyCredit: Pixabay/CC0 Public DomainUsing a web application to qualify individuals for treatment with a non-prescription statin closely matched the results of clinic
Breakthroughs April 28,2024
Optimal timing maximizes Paxlovid benefits for treating COVID-19

Optimal timing maximizes Paxlovid benefits for treating COVID-19

byeLifeCredit: CC0 Public DomainResearchers have described the optimal timing for COVID-19 patients to take the antiviral, Paxlovid, to get the most benefit from the treatment, according to a st
Breakthroughs April 28,2024
Optimal timing maximizes Paxlovid benefits for treating COVID-19

Optimal timing maximizes Paxlovid benefits for treating COVID-19

byeLifeCredit: CC0 Public DomainResearchers have described the optimal timing for COVID-19 patients to take the antiviral, Paxlovid, to get the most benefit from the treatment, according to a st
Breakthroughs April 28,2024
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu... ... Eye Infections (Updated) | Clinical Medicine ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com